Pathway to Cures/NBDF
- Patient advocacy
- Investor (buy-side or sell-side research)
The National Bleeding Disorders Foundation Venture Fund, LLC (Pathway to Cures) exists to support the NBDF in enabling cures for inheritable blood and bleeding disorders and to address and prevent the complications of these disorders. We are focused on first-in-class therapeutics and novel therapeutic mechanisms with the potential to cure, precision diagnostics with the potential to enable earlier or more accurate diagnoses, and novel technologies and platforms with the potential to revolutionize treatments.